Rompala G, Nagamatsu S, Martinez-Magana J, Nunez-Rios D, Wang J, Girgenti M
Nat Commun. 2023; 14(1):4544.
PMID: 37507366
PMC: 10382503.
DOI: 10.1038/s41467-023-40285-y.
Abdulmalek S, Hardiman G
Expert Rev Mol Diagn. 2023; 23(5):361-373.
PMID: 37078260
PMC: 10257799.
DOI: 10.1080/14737159.2023.2190022.
Elfers K, Menne L, Colnaghi L, Hoppe S, Mazzuoli-Weber G
Cells. 2023; 12(4).
PMID: 36831246
PMC: 9954635.
DOI: 10.3390/cells12040577.
Gregoriou G, Patel S, Pyne S, Winters B, Bagley E
J Neurosci. 2023; 43(10):1668-1681.
PMID: 36781220
PMC: 10010477.
DOI: 10.1523/JNEUROSCI.1317-22.2022.
King L, Hayashi K, Genberg B, Choi J, DeBeck K, Kirk G
Drug Alcohol Depend. 2022; 241:109654.
PMID: 36266158
PMC: 9535877.
DOI: 10.1016/j.drugalcdep.2022.109654.
Mechanism of opioid addiction and its intervention therapy: Focusing on the reward circuitry and mu-opioid receptor.
Zhang J, Song C, Dai J, Li L, Yang X, Chen Z
MedComm (2020). 2022; 3(3):e148.
PMID: 35774845
PMC: 9218544.
DOI: 10.1002/mco2.148.
Sleep Disturbance Alters Cocaine-Induced Locomotor Activity: Involvement of Striatal Neuroimmune and Dopamine Signaling.
Roodsari S, Cheng Y, Reed K, Wellman L, Sanford L, Kim W
Biomedicines. 2022; 10(5).
PMID: 35625897
PMC: 9138453.
DOI: 10.3390/biomedicines10051161.
Ginsenoside Rb1 attenuates methamphetamine (METH)-induced neurotoxicity through the NR2B/ERK/CREB/BDNF signalings and models.
Yang G, Li J, Peng Y, Shen B, Li Y, Liu L
J Ginseng Res. 2022; 46(3):426-434.
PMID: 35600772
PMC: 9120644.
DOI: 10.1016/j.jgr.2021.07.005.
Neuroinflammatory Response in Reward-Associated Psychostimulants and Opioids: A Review.
Karimi-Haghighi S, Chavoshinezhad S, Mozafari R, Noorbakhsh F, Borhani-Haghighi A, Haghparast A
Cell Mol Neurobiol. 2022; 43(2):649-682.
PMID: 35461410
PMC: 11415174.
DOI: 10.1007/s10571-022-01223-6.
French-Canadian Translation and Cultural Adaptation of the Clinical Opiate Withdrawal Scale: The COWS-FC.
Bruneau A, Poirier C, Berube M, Boulanger A, Gelinas C, Guenette L
Can J Psychiatry. 2022; 67(9):701-711.
PMID: 35290134
PMC: 9449138.
DOI: 10.1177/07067437221087066.
Anhedonia, Hyperkatifeia, and Negative Reinforcement in Substance Use Disorders.
Koob G
Curr Top Behav Neurosci. 2022; 58:147-165.
PMID: 35112332
DOI: 10.1007/7854_2021_288.
α-Conotoxin TxIB Inhibits Development of Morphine-Induced Conditioned Place Preference in Mice Blocking α6β2* Nicotinic Acetylcholine Receptors.
Li X, Xiong J, Zhang B, Zhangsun D, Luo S
Front Pharmacol. 2021; 12:772990.
PMID: 34925031
PMC: 8681874.
DOI: 10.3389/fphar.2021.772990.
Transcriptional Alterations in Dorsolateral Prefrontal Cortex and Nucleus Accumbens Implicate Neuroinflammation and Synaptic Remodeling in Opioid Use Disorder.
Seney M, Kim S, Glausier J, Hildebrand M, Xue X, Zong W
Biol Psychiatry. 2021; 90(8):550-562.
PMID: 34380600
PMC: 8463497.
DOI: 10.1016/j.biopsych.2021.06.007.
Neurodevelopmental origins of substance use disorders: Evidence from animal models of early-life adversity and addiction.
Levis S, Baram T, Mahler S
Eur J Neurosci. 2021; 55(9-10):2170-2195.
PMID: 33825217
PMC: 8494863.
DOI: 10.1111/ejn.15223.
Cell-type specific expression and behavioral impact of galanin and GalR1 in the locus coeruleus during opioid withdrawal.
Foster S, Galaj E, Karne S, Ferre S, Weinshenker D
Addict Biol. 2021; 26(5):e13037.
PMID: 33768673
PMC: 8376771.
DOI: 10.1111/adb.13037.
Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development.
Koob G
Pharmacol Rev. 2020; 73(1):163-201.
PMID: 33318153
PMC: 7770492.
DOI: 10.1124/pharmrev.120.000083.
Chronic developmental lead exposure increases μ-opiate receptor levels in the adolescent rat brain.
Albores-Garcia D, McGlothan J, Bursac Z, Guilarte T
Neurotoxicology. 2020; 82:119-129.
PMID: 33248188
PMC: 7855666.
DOI: 10.1016/j.neuro.2020.11.008.
Signaling models for dopamine-dependent temporal contiguity in striatal synaptic plasticity.
Urakubo H, Yagishita S, Kasai H, Ishii S
PLoS Comput Biol. 2020; 16(7):e1008078.
PMID: 32701987
PMC: 7402527.
DOI: 10.1371/journal.pcbi.1008078.
Cannabidiol attenuates methamphetamine-induced conditioned place preference via the Sigma1R/AKT/GSK-3β/CREB signaling pathway in rats.
Yang G, Liu L, Zhang R, Li J, Leung C, Huang J
Toxicol Res (Camb). 2020; 9(3):202-211.
PMID: 32670551
PMC: 7329178.
DOI: 10.1093/toxres/tfaa021.
Periaqueductal Gray and Rostromedial Tegmental Inhibitory Afferents to VTA Have Distinct Synaptic Plasticity and Opiate Sensitivity.
St Laurent R, Martinez Damonte V, Tsuda A, Kauer J
Neuron. 2020; 106(4):624-636.e4.
PMID: 32191871
PMC: 7244388.
DOI: 10.1016/j.neuron.2020.02.029.